Development of Lymphopenia during Therapy with Immune Checkpoint Inhibitors Is Associated with Poor Outcome in Metastatic Cutaneous Melanoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Cancers 14.13 (2022): 3282.
- Ereignis
-
Veröffentlichung
- (wo)
-
Erlangen
- (wer)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (wann)
-
2022
- Urheber
-
Tomsitz, Dirk
Schlaak, Max
Zierold, Sarah
Pesch, Giulia
Schulz, Thomas U.
Müller, Genoveva
Zecha, Christine
French, Lars E.
Heinzerling, Lucie
- DOI
-
10.3390/cancers14133282
- URN
-
urn:nbn:de:bvb:29-opus4-199550
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:47 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tomsitz, Dirk
- Schlaak, Max
- Zierold, Sarah
- Pesch, Giulia
- Schulz, Thomas U.
- Müller, Genoveva
- Zecha, Christine
- French, Lars E.
- Heinzerling, Lucie
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Entstanden
- 2022
Ähnliche Objekte (12)
Immune checkpoint inhibitor triggered parkinsonism in a patient with metastatic melanoma
Primary Resistance to Immune Checkpoint Inhibitors in Patients with Metastatic Melanoma : Prognosis, Subsequent Therapies and Survival
Determinants of survival in patients with brain metastases from cutaneous melanoma
Functional immunological parameters associated with long-term survival of patients with metastatic melanoma
Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study
Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Re-Induction following Resistance or Toxicity
DNA methylation-based prediction of response to immune checkpoint inhibition in metastatic melanoma
Efficacy and safety of ripretinib in patients with KIT-altered metastatic melanoma
The impact of brain involvement in metastatic melanoma patients treated with Pembrolizumab [Abstract]
Sex hormones influence survival of patients with metastatic urothelial carcinoma undergoing immune checkpoint therapy
Dynamic optical coherence tomography of blood vessels in cutaneous melanoma — correlation with histology, immunohistochemistry and dermoscopy
Digital quantification of tumor PD-L1 predicts outcome of PD-1-based immune checkpoint therapy in metastatic melanoma
Immune checkpoint inhibitor triggered parkinsonism in a patient with metastatic melanoma
Primary Resistance to Immune Checkpoint Inhibitors in Patients with Metastatic Melanoma : Prognosis, Subsequent Therapies and Survival
Determinants of survival in patients with brain metastases from cutaneous melanoma
Functional immunological parameters associated with long-term survival of patients with metastatic melanoma
Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study
Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Re-Induction following Resistance or Toxicity
DNA methylation-based prediction of response to immune checkpoint inhibition in metastatic melanoma
Efficacy and safety of ripretinib in patients with KIT-altered metastatic melanoma
The impact of brain involvement in metastatic melanoma patients treated with Pembrolizumab [Abstract]
Sex hormones influence survival of patients with metastatic urothelial carcinoma undergoing immune checkpoint therapy
Dynamic optical coherence tomography of blood vessels in cutaneous melanoma — correlation with histology, immunohistochemistry and dermoscopy
Digital quantification of tumor PD-L1 predicts outcome of PD-1-based immune checkpoint therapy in metastatic melanoma
Immune checkpoint inhibitor triggered parkinsonism in a patient with metastatic melanoma
Primary Resistance to Immune Checkpoint Inhibitors in Patients with Metastatic Melanoma : Prognosis, Subsequent Therapies and Survival
Determinants of survival in patients with brain metastases from cutaneous melanoma
Functional immunological parameters associated with long-term survival of patients with metastatic melanoma
Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study
Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Re-Induction following Resistance or Toxicity
DNA methylation-based prediction of response to immune checkpoint inhibition in metastatic melanoma
Efficacy and safety of ripretinib in patients with KIT-altered metastatic melanoma
The impact of brain involvement in metastatic melanoma patients treated with Pembrolizumab [Abstract]
Sex hormones influence survival of patients with metastatic urothelial carcinoma undergoing immune checkpoint therapy
Dynamic optical coherence tomography of blood vessels in cutaneous melanoma — correlation with histology, immunohistochemistry and dermoscopy